Moral Challenges, Moral Distress, and Moral Resilience in Critical Care Nurses During the COVID-19 Pandemic
Authors
Malatesta, Thin ZarFaculty Advisor
Carol BovaUMass Chan Affiliations
Graduate School of NursingDocument Type
Doctoral DissertationPublication Date
2021-09-24Keywords
moral challengesmoral distress
moral resilience
critical care nurses
covid-19 pandemic
ICU
Nursing
Metadata
Show full item recordAbstract
PURPOSE: The purpose of this qualitative descriptive study was to describe critical care nurses’ experiences of moral challenges, moral distress, and moral resilience during the COVID-19 pandemic. The specific aims of this study were to: 1. Describe the moral challenges experienced by ICU nurses. 2. Describe moral resilience in terms of integrity, buoyancy, moral efficacy, self-regulation, and self-stewardship among ICU nurses (from Rushton’s framework). 3. Explore the relationship between moral distress and moral resilience to advance the concept of moral resilience in the face of the COVID-19 pandemic. FRAMEWORK: This study was undergirded by an adaptation of Rushton’s conceptual framework of moral concepts. DESIGN: A qualitative descriptive design was used. Participants were recruited between January to May 2021, and a semi-structured interview guide was utilized to interview participants. RESULTS: 17 participants were interviewed for the study. Participants described the four themes of moral challenges: death and dying, pain and suffering, being alone, and being helpless and not in control. Moral resilience was described as: integrity, buoyancy, moral efficacy, self-regulation, self-stewardship, and self-perception. The relationship between moral distress and moral resilience was described as iterative and fluid. CONCLUSION: The findings of the study provided a new domain of moral resilience called self-perception and a revised adaptation of the conceptual framework for moral resilience.DOI
10.13028/31tt-qz33Permanent Link to this Item
http://hdl.handle.net/20.500.14038/34417Rights
Copyright © 2021 MalatestaDistribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.13028/31tt-qz33
Scopus Count
Related items
Showing items related by title, author, creator and subject.
-
The non-canonical SMC protein SmcHD1 antagonises TAD formation and compartmentalisation on the inactive X chromosomeGdula, Michal R.; Nesterova, Tatyana B.; Pintacuda, Greta; Godwin, Jonathan; Zhan, Ye; Ozadam, Hakan; McClellan, Michael; Moralli, Daniella; Krueger, Felix; Green, Catherine M.; et al. (2019-01-03)The inactive X chromosome (Xi) in female mammals adopts an atypical higher-order chromatin structure, manifested as a global loss of local topologically associated domains (TADs), A/B compartments and formation of two mega-domains. Here we demonstrate that the non-canonical SMC family protein, SmcHD1, which is important for gene silencing on Xi, contributes to this unique chromosome architecture. Specifically, allelic mapping of the transcriptome and epigenome in SmcHD1 mutant cells reveals the appearance of sub-megabase domains defined by gene activation, CpG hypermethylation and depletion of Polycomb-mediated H3K27me3. These domains, which correlate with sites of SmcHD1 enrichment on Xi in wild-type cells, additionally adopt features of active X chromosome higher-order chromosome architecture, including A/B compartments and partial restoration of TAD boundaries. Xi chromosome architecture changes also occurred following SmcHD1 knockout in a somatic cell model, but in this case, independent of Xi gene derepression. We conclude that SmcHD1 is a key factor in defining the unique chromosome architecture of Xi.
-
Data Curation and Management Competencies of New England Region Health Sciences and Science and Technology LibrariansCreamer, Andrew T.; Morales, Myrna E.; Crespo, Javier; Kafel, Donna; Martin, Elaine Russo (2011-04-06)Objective: To identify specific data curation and management competencies that would aid in the continued development of a data management curriculum and professional development supporting New England health sciences and science and technology librarians, and to gather data on the nature and progress of data services being provided by these librarians and those being demanded by their patrons. Methodology: Based on a content analysis of data services and e-science librarian job postings, selected library and information science schools¹ programs and curricula, and published case studies and related best practices, the team researched and developed questions for the survey. An assessment was created using SurveyMonkey. A small group of medical librarians tested the survey and offered feedback. The survey was revised and then disseminated to New England health sciences and science and technology librarians. After three weeks, the team collected and analyzed the results. Results and Conclusion: A quarter of respondents surveyed stated that they are already managing and curating data sets. This number has nearly doubled since the team's 2009 assessment of New England health sciences and science and technology librarians engaged in e-science. Almost half of respondents will be providing these services in the future; almost three quarters of respondents stated their library has or is in the process of creating a data management policy. Their responses to the competencies suggest that the portal curriculum focus on technical resources that would develop librarians¹ competencies in data literacy, curation and management by teaching skills such as scripting and programming languages and metadata and interoperability standards, as well as skills necessary to administer an institutional data repository. The data also suggest that a curriculum provide resources that address the non-technical competencies necessary to develop a data management policy, understand intellectual property and scholarly communication related to data. This research is helping the University of Massachusetts Medical School Lamar Soutter Library and National Network of National Libraries of Medicine New England Region (NN/LM NER) to develop its E-Science Portal data management curriculum and in-person professional development programming for its regional librarians engaged in e-science activities. In addition, this assessment illuminates the many challenges that health sciences libraries in New England are facing trying to engage in e-science. Thus, an area for future investigation is the strategies that libraries are using to deal with these challenges and overcome these obstacles.
-
Body mass index and treatment survival in patients with RA starting treatment with TNFalpha-inhibitors: long-term follow-up in the real-life METEOR registryBergstra, Sytske Anne; Allaart, Cornelia F.; Vega-Morales, David; De Buck, Marieke; Murphy, Elizabeth; Salomon-Escoto, Karen I.; Huizinga, Tom W. J. (2020-06-06)OBJECTIVES: To study whether there is an association between body mass index (BMI) category and survival of various tumour necrosis factor inhibitors (TNFi) in rheumatoid arthritis (RA) patients in a real-life longitudinal international registry. METHODS: Data from 5230 patients with RA starting treatment with any TNFi were selected from the METEOR registry. Patients were divided into six BMI categories: 3.7% underweight, BMI < 18.5 kg/m(2); 46% normal weight, BMI 18.5-25 kg/m(2); 32% pre-obesity, BMI 25-30 kg/m(2); 13% obesity class I, BMI 30-35 kg/m(2); 3.4% obesity class II, BMI 35-40 kg/m(2); and 1.6% obesity class III, BMI > 40 kg/m(2). Time on treatment in the different BMI categories was compared for all TNFi combined and for the infliximab, adalimumab and etanercept separately, using Kaplan-Meier curves and Cox regression analyses. Cox regression analyses were adjusted for potential confounders, with follow-up censored at 5000 days. RESULTS: Patients in obesity class II (HR 1.28, 95% CI 1.06 to 1.54) and III (HR 1.67, 95% CI 1.29 to 2.18) and underweight patients (HR 1.30, 95% CI 1.07 to 1.58) showed statistically significantly shorter TNFi survival than normal weight patients. The effect in underweight patients was strongest for infliximab (HR 1.82, 95% CI 1.20 to 2.76), the effect in overweight patients was strongest for infliximab (category II (HR 1.49, 95% CI 0.98 to 2.26); category III (HR 1.46, 95% CI 0.79 to 2.71)) and etanercept (category II (HR 1.27 95% CI 0.98 to 1.65); category III (HR 1.79, 95% CI 1.25 to 2.55)). No significant effect modification from reported pain was found. CONCLUSION: Both underweight and overweight patients discontinued TNFi treatment earlier than normal weight patients, without evidence of reported pain as the main determinant. It remains uncertain what determines TNFi survival in individual patients.